Results 31 to 40 of about 4,735 (197)

Dutasteride and Prostate Cancer [PDF]

New England Journal of Medicine, 2010
Contains fulltext : 88812.pdf (Publisher’s version ) (Open Access)
Kiemeney, L.A.L.M., Bosland, M.C.
openaire   +7 more sources

Cost effectiveness comparison of dutasteride and finasteride in patients with benign prostatic hyperplasia - the Markov model based on data from Montenegro [PDF]

Vojnosanitetski Pregled, 2016
Background/Aim. Benign prostatic hyperplasia (BPH) is one of the most common disease among males aging 50 years and more. The rise of the prevalence of BPH is related to aging, and since duration of life time period has the tendency of rising ...
Dabanović Vera, Kostić Marina, Janković Slobodan   +2 more
doaj   +1 more source

Preparation and Characterization of Dutasteride Nanoparticles as Oral Fast-Dissolving Film

مجلة كلية الطب
Background: Dutasteride, is a drug whose mechanism of action is inhibition of the enzyme 5-alpha reductase. It has been approved for use in the treatment of benign prostatic hyperplasia.
Rusul W. Kadhum, Shaimaa N. Abd-Alhammid   +1 more
doaj   +1 more source

Early Dutasteride Monotherapy in Patients With Elevated Serum Prostate-Specific Antigen Levels Following Robot-Assisted Radical Prostatectomy

Frontiers in Oncology, 2019
Background: To evaluate the efficacy of early dutasteride administration in patients with a detectable prostate-specific antigen (PSA) levels after robot-assisted radical prostatectomy (RARP).Methods: We retrospectively analyzed RARP patients whose ...
Chin-Heng Lu, Yen-Chuan Ou, Li-Hua Huang, Wei-Chun Weng, Yu-Kang Chang, Hung-Lin Chen, Chao-Yu Hsu, Min-Che Tung   +7 more
doaj   +1 more source

The Effect of Dutasteride on Magnetic Resonance Imaging Defined Prostate Cancer: MAPPED—A Randomized, Placebo Controlled, Double-Blind Clinical Trial

, 2017
Purpose: Dutasteride, which is licensed for symptomatic benign prostatic hyperplasia, has been associated with a lower progression rate of low risk prostate cancer.
Moore, C.M., Giganti, F., Jameson, C., Jichi, F., Mitra, A.V., Ridout, A.J., Emberton, M., Kirkham, A., Winkler, M., Freeman, A., Damola, A., Ambler, G., Ahmed, H.U., Whitcher, B., Castro, R., Allen, C., Arya, M., Bott, S.R.J., Robertson, N.L., Gambarota, G., McCartan, N.   +20 more
core   +1 more source

Inhibitory Effects of Dutasteride on TLR4: An In vitro Pain Study

Iranian Journal of Allergy, Asthma and Immunology, 2022
Dutasteride was potentially proposed to control chronic pain by Toll-Like Receptor 4 (TLR4) inhibition through its effect on TLR4 expression, Myeloid differentiation primary response 88 (MyD88), Nuclear factor kappa-light-chain-enhancer of activated B ...
Leila Taheran, Hakimeh Zali, Kazem Sharifi, Mohsen Yazdani, Mohammad Ajoudanian, Mir-Shahram Safari, Samira Rajaei, Ali Dabbagh   +7 more
doaj   +1 more source

Comparison between dutasteride and finasteride in hair regrowth and reversal of miniaturization in male and female androgenetic alopecia: a systematic review

Dermatology Reports
Nowadays androgenetic alopecia (AGA) has become a common concern of affected subjects of both sexes. Finasteride is approved by the Food and Drug Administration for the treatment of male AGA.
Almuntaserbellah Almudaimeegh, Hanadi AlMutairi, Fatimah AlTassan, Yomna AlQuraishi, Khalid Nabil Nagshabandi   +4 more
doaj   +1 more source

Is Dutasteride a Therapeutic Alternative for Amyotrophic Lateral Sclerosis? [PDF]

, 2022
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that is characterized by the loss of upper and lower motor neurons (MNs) in the cerebral cortex, brainstem and spinal cord, with consequent weakness, atrophy and the progressive paralysis
Lajara-Romance, Jose María, Rodriguez-Mateos, Ana; id_orcid, Jose Enrique de la Rubia Ortí, Casani-Cubel, Julia, Rodriguez Mateos, Ana, Rodriguez-Mateos, Ana, Julia Casani-Cubel, Navarro-Illana, Esther, Casani Cubel, Julia, Proaño, Belén, Jose María Lajara-Romance, Ana Rodriguez-Mateos, Lajara Romance, José María, Proaño Olmos, Belén, Belén Proaño, Esther Navarro-Illana, de la Rubia Ortí, Jose Enrique, Benlloch García, María, Benlloch, María, María Benlloch, Navarro Illana, Esther   +20 more
core   +1 more source

Interventional Radiology Society of Australasia Quality Care Guidelines for Prostate Artery Embolisation for Men With Symptomatic Benign Prostatic Hyperplasia in Australia and New Zealand

Journal of Medical Imaging and Radiation Oncology, EarlyView.
ABSTRACT Objective This guideline defines recommendations for the provision of quality care for prostate artery embolisation (PAE) treatment for symptomatic benign prostatic hyperplasia (BPH). It has been developed using the AGREE‐II framework and aligns with current evidence, sourced from Randomised Controlled Trials, meta‐analyses and expert ...
William E. L. Ormiston, Glen Schlaphoff, Andrew Owen, Brendan Buckley, Dinesh Ranatunga, Christopher Rogan, Nicholas I. Brown   +6 more
wiley   +1 more source

Effect of dutasteride treatment on reducing blood loss and in perioperative period of open prostatectomy

Urology Research and Practice, 2019
Objective: Open prostatectomy (OP) is a valid option for the surgical treatment of large prostates in the absence of holmium laser enucleation. The most frequent complication of OP is intra- and perioperative bleeding. Preoperative use of dutasteride has
Mehmet İlker Gökçe, Seymur Kerimov, Aykut Akıncı, Nurullah Hamidi, Faraj Afandiyev, Önder Yaman   +5 more
doaj   +1 more source